Y-Intercept (HK)’s Mirum Pharmaceuticals MIRM Stock Holding History

Y-Intercept (HK)’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$548K	Buy	+6,413	New	+$669K	0.01%	1260
2026 Q1	–	Sell	-14,368	Closed	-$1.13M	–	1867
2025 Q4	$1.13M	Buy	14,368 +3,343	+30%	+$240K	0.03%	924
2025 Q3	$808K	Buy	+11,025	New	+$701K	0.02%	1074
2024 Q4	–	Sell	-5,516	Closed	-$215K	–	1478
2024 Q3	$215K	Buy	+5,516	New	+$220K	0.01%	1134

Other funds holding MIRM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Y-Intercept (HK)'s MIRM Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Mirum Pharmaceuticals (MIRM) in Q3 2026: 6,413 shares worth $548K. The stake represents 0.01% of the portfolio and ranks #1260 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in MIRM as recently as Q4 2025.

Y-Intercept (HK) first reported a position in MIRM in Q3 2024 and has held it in 4 quarters since. The position peaked at $1.13M in Q4 2025. 172 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

Y-Intercept (HK) held 6,413 shares of Mirum Pharmaceuticals worth $548K as of Q3 2026.
Mirum Pharmaceuticals was a new Y-Intercept (HK) position in Q3 2026.
Mirum Pharmaceuticals made up 0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1260 holding.
Y-Intercept (HK) first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
Y-Intercept (HK)'s Mirum Pharmaceuticals position peaked at $1.13M in Q4 2025.
172 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.